Circulating Tumor Cell Detection and Analysis to Support Malignancy Designation, Tumor-of-Origin Identification, and Treatment Selection

October 25, 2023
Circulating tumor cells (CTCs) are cells that leave the primary tumor and are intravasated into the blood circulation system. A subset of those make it to other organs and are responsible for metastasis. iCellate’s CellMate platform is a CTC-based liquid biopsy for cancer cell enrichment, detection, and biomarker analysis via a simple blood draw.

In this seminar, you’ll learn:

From Helena Silva Cascales, senior scientist at iCellate Medical AB, how the isolation of whole-tumor cells provides a more comprehensive biomarker analysis, including genomic sequencing and multiplexed protein expression analysis.
From Kashyap Dave, principal scientist at iCellate Medical AB, how DNA from single CTCs can be amplified, sequenced, and analyzed to support malignancy designation and tissue of origin identification using classification analyses under development within Qiagen CLC Genomics Workbench.

Related videos


QIAGEN CLC Main Workbench training

5,921 views December 21, 2020

Day 1: QIAGEN CLC Main Workbench Speaker: Shawn Prince, Sr. Field...

Web seminar recordings

Biologically interpret your RNA-seq data with knowledge-based IPA

5,499 views September 22, 2017

This webinar will provide an overview of how to analyze data obtained from...

Discovery and Research

QIAGEN CLC Genomics Workbench 20 – scalable desktop software for NGS data analysis

4,781 views January 28, 2020

In this webinar, Leif Schauser, Ph.D., Director Product Management Genome...

Web seminar recordings

Data analysis on day one - Taxonomic and functional microbiome profiling with the Microbial...

3,457 views December 20, 2017

In this webinar, we will introduce the scientist-friendly Microbial Genomics...